NCT05641792

Brief Summary

CLUE trial aims to determine the feasibility and predictive value for surgical site infection (SSI) of continuous glucose monitoring (CGM) in emergency laparotomy patients with diffuse peritonitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

March 15, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

February 2, 2023

Status Verified

February 1, 2023

Enrollment Period

1.7 years

First QC Date

November 29, 2022

Last Update Submit

February 1, 2023

Conditions

Keywords

continuous glucose monitoringCGMDexcom G6

Outcome Measures

Primary Outcomes (1)

  • feasibility of CGM system

    measured as the drop-out rate caused by non-adherence of both patients and medical staff due to system detaching, problems with the receiving device (low battery. distance beyond Bluetooth communication range) etc.

    10 days

Secondary Outcomes (4)

  • intra- and post-operative glycemia

    10 days

  • postoperative morbidity

    30 days

  • SSI rate

    30 days

  • effective wound closure

    30 days

Study Arms (1)

CGM pre-, intra- and postoperatively

EXPERIMENTAL

Patients will have a Dexcom G6 system placed on admission on outer part of the arm, glycaemia will be monitored for 10 consecutive days

Device: CGM (Dexcom G6)

Interventions

Dexcom G6 system consists of a transmitter and sensor that measure interstitial glycaemia every 5 minutes. Measurements are transmitted via Bluetooth to a compatible device, that uploads the data on a virtual drive. This allows for remote real-time glycaemia monitoring on another device.

Also known as: continuous glucose monitoring, CGM, Dexcom G6
CGM pre-, intra- and postoperatively

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • emergency laparotomy for peritonitis
  • written informed consent

You may not qualify if:

  • \- open abdomen treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCC Division of Oncological, Transplant and General Surgery

Gdansk, Pomeranian Voivodeship, 80952, Poland

Location

MeSH Terms

Conditions

PeritonitisSurgical Wound InfectionInfectionsHyperglycemiaHypoglycemia

Interventions

Continuous Glucose Monitoring

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsPeritoneal DiseasesDigestive System DiseasesWound InfectionPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicInvestigative Techniques

Study Officials

  • Piotr Spychalski, MD, PhD

    MUG Division of General Surgery

    PRINCIPAL INVESTIGATOR
  • Katarzyna Polomska

    Medical University of Gdansk (MUG)

    PRINCIPAL INVESTIGATOR
  • Jaroslaw Kobiela, Prof.

    MUG Division of General Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katarzyna M Polomska

CONTACT

Piotr Spychalski, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2022

First Posted

December 8, 2022

Study Start

March 15, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

February 2, 2023

Record last verified: 2023-02

Locations